Corvus Pharmaceuticals Inc. logo

Corvus Pharmaceuticals Inc.

CRVS | NASDAQ
Chart Builder DCF Calculator
$12.42
-$0.14 (-1.11%)
At close: Sep 21, 2026, 4:00 PM ET
$12.42
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
4.58M 8.74M 12.62M 13.16M 63.46M 16.46M
Short-Term Investments
52.17M 43.22M 14.53M 29.14M 5.99M 27.8M
Long-Term Investments
10.99M 12.54M 16.12M 21.88M 34.27M 37.23M
Other Long-Term Assets
855K 632K 89K 129K 236K 414K
Receivables
374K 216K 63K 633K 539K n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
318K 548K 220K 102K 128K 673K
Total Current Assets
58.21M 54.41M 27.96M 43.66M 71.31M 45.34M
Property-Plant & Equipment
1.06M 1.33M 1.39M 2.57M 3.64M 2.55M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
12.91M 14.5M 17.6M 24.58M 38.14M 40.19M
Total Assets
71.12M 68.91M 45.55M 68.24M 109.46M 85.53M
Account Payables
2.49M 2.58M 1.53M 1.98M 1.57M 3.47M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
403K n/a n/a n/a n/a n/a
Other Current Liabilities
5.85M 30.02M 929K 1.27M 1.97M 180K
Total Current Liabilities
9.38M 35.4M 6.87M 10.75M 9.69M 12.15M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
534K 937K n/a 1.37M 2.6M 1.23M
Total Liabilities
9.91M 36.34M 6.87M 12.13M 12.29M 13.38M
Total Debt
937K 1.12M 1.37M 2.6M 3.65M 2.31M
Book Value
61.21M 32.57M 38.68M 56.12M 97.16M 72.15M
Book Value Per Share
0.77 0.53 0.81 1.21 2.32 2.45
Common Stock
7K 7K 5K 5K 5K 3K
Retained Earnings
-412.29M -397.01M -334.72M -307.69M -266.38M -223.14M
Comprehensive Income
-896K -1.29M -967K -563K 1.87M 4K
Shareholders Equity
61.21M 32.57M 38.68M 56.12M 97.16M 72.15M
Total Investments
63.17M 55.76M 30.65M 51.02M 40.26M 65.03M

© 2026 bestshares.com. All rights reserved.